首页> International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases> Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report.

Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report.

导出 OA

翻译打印收藏纠错

第一作者： Marco,Franzetti

第一单位： Infectious Diseases Unit, A. Manzoni Hospital, Lecco, Italy. Electronic address: m.franzetti@asst-lecco.it.

作者： Marco,Franzetti ^[1] ; Ugo,Pozzetti ^[2] ; Manuela,Carugati ^[3] ; Alessandro,Pandolfo ^[4] ; Chiara,Molteni ^[4] ; Paolo,Faccioli ^[5] ; Gioacchino,Castaldo ^[4] ; Ernesto,Longoni ^[4] ; Valentina,Ormas ^[6] ; Enrico,Iemoli ^[7] ; Stefania,Piconi ^[4]

作者单位： Infectious Diseases Unit, A. Manzoni Hospital, Lecco, Italy. Electronic address: m.franzetti@asst-lecco.it. ^[1] Medicine Department, A. Manzoni Hospital, Lecco, Italy. ^[2] Division of Infectious Diseases, Duke University, Durham, United States; ATS Brianza, Lecco, Italy. ^[3] Infectious Diseases Unit, A. Manzoni Hospital, Lecco, Italy. ^[4] Radiology Unit, Alessandro Manzoni Hospital, Lecco, Italy. ^[5] Intensive Care Unit, Manzoni Hospital, Lecco, Italy. ^[6] First Infectious Diseases Department and Allergy and Clinical Immunology Unit, L. Sacco Hospital, Milan, Italy. ^[7]

关键词 Anakinra Cytokine-release syndrome Interleukin-1 receptor antagonist Novel coronavirus disease 2019 (COVID-19)Remdesivir